96 related articles for article (PubMed ID: 12185598)
21. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
[TBL] [Abstract][Full Text] [Related]
22. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of the porcine deleted in malignant brain tumors 1 gene (DMBT1).
Haase B; Humphray SJ; Lyer S; Renner M; Poustka A; Mollenhauer J; Leeb T
Gene; 2006 Jul; 376(2):184-91. PubMed ID: 16624504
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas.
Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA
Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843
[TBL] [Abstract][Full Text] [Related]
25. High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan.
Chen FM; Hou MF; Chang MY; Wang JY; Hsieh JS; Ou-Yang F; Huang TJ; Lin SR
Cancer Lett; 2005 Apr; 220(2):177-84. PubMed ID: 15766593
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
Mueller W; Lass U; Wellmann S; Kunitz F; von Deimling A
Acta Neuropathol; 2005 Mar; 109(3):314-20. PubMed ID: 15668788
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma.
Imai MA; Moriya T; Imai FL; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
Int J Mol Med; 2005 Apr; 15(4):585-9. PubMed ID: 15754018
[TBL] [Abstract][Full Text] [Related]
28. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Finkelstein SD; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Finlay JL; Sposto R;
Cancer Res; 2001 Oct; 61(20):7404-7. PubMed ID: 11606370
[TBL] [Abstract][Full Text] [Related]
29. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H
J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620
[TBL] [Abstract][Full Text] [Related]
30. Low level of microsatellite instability in paediatric malignant astrocytomas.
Vladimirova V; Denkhaus D; Soerensen N; Wagner S; Wolff JE; Pietsch T
Neuropathol Appl Neurobiol; 2008 Oct; 34(5):547-54. PubMed ID: 18053027
[TBL] [Abstract][Full Text] [Related]
31. KLF6: mutational analysis and effect on cancer cell proliferation.
Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
[TBL] [Abstract][Full Text] [Related]
32. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
33. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
35. Identification of regulatory regions of the putative tumor suppressor gene DMBT1.
Lualdi E; Chiariello E; Finocchiaro G
Biochem Biophys Res Commun; 2000 Apr; 270(2):673-5. PubMed ID: 10753682
[TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
[TBL] [Abstract][Full Text] [Related]
37. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.
Hartmann C; Nümann A; Mueller W; Holtkamp N; Simon M; von Deimling A
Int J Cancer; 2004 Mar; 108(6):839-44. PubMed ID: 14712485
[TBL] [Abstract][Full Text] [Related]
38. Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.
Kim Y; Hong HH; Lachat Y; Clayton NP; Devereux TR; Melnick RL; Hegi ME; Sills RC
Toxicol Pathol; 2005; 33(3):307-12. PubMed ID: 15814359
[TBL] [Abstract][Full Text] [Related]
39. A highly sensitive detection method for somatic mutations in p53 gene.
Sato T; Sato A; Ishihara H; Konishi K
Rinsho Byori; 2003 Feb; 51(2):98-106. PubMed ID: 12690626
[TBL] [Abstract][Full Text] [Related]
40. Mutations of the p53 gene in gliomas from Malay patients.
Jafri A; Aziz MY; Ros S; Nizam I
Med J Malaysia; 2003 Jun; 58(2):236-42. PubMed ID: 14569744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]